Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin, glipizide GITS, or combination therapy in newly diagnosed non-obese type 2 diabetes
ChiCTR-TRC-10000941Phase 4Completed
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of metformin and glipizide in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Nanjing Drum-Tower Hospital. Primary endpoints: HbA1c, Proportion achieving HbA1c <7.0% and 1 more. Started May 2010; status: completed.
02
Drugs
metforminglipizide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-TRC-10000941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000941.